Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 HKD | 0.00% | 0.00% | +15.24% |
03-26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
03-25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
1st Jan change | Capi. | |
---|---|---|
+15.24% | 233M | |
+32.36% | 694B | |
+29.59% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.51% | 239B | |
-3.48% | 209B | |
+10.07% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 2348 Stock
- News Dawnrays Pharmaceutical (Holdings) Limited
- Dawnrays Pharmaceutical Limited's Equity Buyback announced on August 27, 2020, has expired with 49,088,000 shares, representing 3.26% for HKD 61.39 million.